Attana and AroCell initiates discussion for collaboration

Report this content

Attana can today announce that the company has initiated a discussion about a new collaboration with the in vitro diagnostics company AroCell AB (Publ).

AroCell AB is a Swedish company that develops and markets blood and urine sample tests and specializes in oncology and bacteriology. The company has a broad product portfolio that is used in healthcare and is established in various markets. The collaboration aims to exchange valuable knowledge in quality and product development, while AroCell's biomarkers can eventually be used on Attana's instruments.

Teodor Aastrup, CEO Attana comments:
“AroCell's long experience in the diagnostics market can help us on the path to growth in new parts of the diagnostics market. The collaboration is an important step in our strategy to establish Attana's technology as a platform in in vitro diagnostics. In addition, we already have good relations with AroCell, which means that we see that the collaboration can start quickly.” says Teodor Aastrup, founder and CEO of Attana.

Anders Hultman, CEO AroCell comments:
“We are pleased to be able to inform that discussions are ongoing with Attana. Attana is a very interesting partner that could support us both in quality assurance of production and product development.” says Anders Hultman, AroCell's CEO, and continues, "The opportunity to analyze our biomarkers for IVD customers on Attana's instruments is also a very interesting way forward."

For more information, please contact:

Teodor Aastrup, CEO
+46 (0)8 674 57 00

The Board of directors for Attana consider that the information in this press release is not likely to have a significant effect on the share price but is of general interest for the shareholders and hence should be communicated.

About Attana

Attana was founded in 2002 with the vision of in vitro characterization of molecular interactions mimicking in vivo conditions. Since then, Attana has developed proprietary label free biosensors for biochemical, crude, sera, and cell-based assays and the Attana Virus Analytics (AVA) platform, a proprietary in vitro diagnostics (IVD) tool. Attana products and research services are used by Big Pharma, biotech companies and academic institutions within the life sciences. To learn more about our latest services and products, please visit or contact





Documents & Links